Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Equity Average (2017 - 2020)

Trinity Biotech (TRIB) has disclosed Equity Average for 4 consecutive years, with $1.2 million as the latest value for Q4 2020.

  • Quarterly Equity Average fell 94.89% to $1.2 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2020, down 94.89% year-over-year, with the annual reading at $1.2 million for FY2020, 94.89% down from the prior year.
  • Equity Average hit $1.2 million in Q4 2020 for Trinity Biotech, down from $24.4 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $87.0 million in Q4 2017 to a low of $1.2 million in Q4 2020.
  • Historically, Equity Average has averaged $41.8 million across 4 years, with a median of $39.5 million in 2018.
  • Biggest five-year swings in Equity Average: tumbled 37.18% in 2018 and later crashed 94.89% in 2020.
  • Year by year, Equity Average stood at $87.0 million in 2017, then crashed by 37.18% to $54.6 million in 2018, then crashed by 55.36% to $24.4 million in 2019, then plummeted by 94.89% to $1.2 million in 2020.
  • Business Quant data shows Equity Average for TRIB at $1.2 million in Q4 2020, $24.4 million in Q4 2019, and $54.6 million in Q4 2018.